Vitamin D Receptor and p21/WAF1 Are Targets of Genistein and 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cells

Cancer Research

Volumn 64, Issue 6, 2004, Pages 2143-2147

  Rao, Anuradha ^a   Coan, April ^a   Welsh, Jo Ellen ^b   Barclay, Wendy W ^a   Koumenis, Constantinos ^a   Cramer, Scott D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; GENISTEIN; PROTEIN P21; SMALL INTERFERING RNA; VITAMIN D RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG SYNERGISM; ENZYME INHIBITORS; GENISTEIN; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 1542720378     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3480     Document Type: Article

References (22)

1. Severeson R, Nomura A, Grove J, Stemmermann G. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-60.
2. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990;10:1307-11.
3. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer (Phila.) 1992;70: 2861-9.
4. Lamartiniere C, Cotroneo M, Fritz W, et al. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002;132:552S-8S.
5. 3 in fish and liver oils and eel body oils. J Nutr Sci Vitaminol 1984;30:421-30.
6. Holick M. Vitamin D: photobiology, metabolism, mechanism of action. In: Favus M, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed. Philadelphia: Lippencott-Raven; 1996. p. 74-81.
7. Zinser G, McEleney K, Welsh J. Characterization of mammary tumor cell lines from wild type and vitamin D receptor knockout mice. Mol Cell Endocrinol 2003;200: 67-80.
8. Davis J, Singh B, Bhuiyan M, Sarkar F. Genistein-induced upregulation of p21, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 1998;32:123-31.
9. 1 cell-cycle arrest in human prostate cancer cells. Mol Carcinog 2000;29:92-102.
10. 1 accumulation. Endocrinology 1998;139: 1197-207.
11. 3 are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res 2001;61:7122-9.
12. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996;10:142-53.
13. Rao A, Woodruff R, Wade W, Kute T, Cramer S. Synergistic inhibition of prostatic epithelial cell growth by genistein and vitamin D. J Nutr 2002;132:3191-4.
14. 3-mediated growth inhibition of primary mouse cells. J Biol Chem 2002;277:37301-6.
15. Schwartz B, Smirnoff P, Shany S, Liel Y. Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Mol Cell Biochem 2000;203:87-93.
16. 3-mediated gene expression and calcium transport in Caco-2 cells. J Bone Miner Res 2001;16:615-25.
17. 3 actions in human breast cancer cells. J Steroid Biochem Mol Biol 2003;84:149-57.
18. 3 among MCF-7 clones correlates with vitamin D receptor protein induction. J Steroid Biochem Mol Biol 2002;81:123-33.
19. Farhan H, Wahala K, Cross H. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cancer cells. J Steroid Biochem Mol Biol 2003;84: 423-9.
20. Xiong Y, Hannon G, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.) 1993;366:701-4.
21. Polyak K, Lee M, Erdjument-Brommage H, et al. Cloning of p27KIP1 a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78:59-66.
22. 3 on primary cultures of human prostatic cells. Cancer Res 1994;54:805-10.